End-stage liver disease patients at lower risk for death in the short term still reaped the substantial benefits of a living-donor liver transplant (LDLT), a case-control study revealed.
CU Anschutz
Academic Office One
12631 East 17th Avenue
Room: 6111
Aurora, CO 80045